Growth Metrics

Neogenomics (NEO) Non-Current Assets (2016 - 2026)

Neogenomics filings provide 17 years of Non-Current Assets readings, the most recent being $972.8 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 5.32% to $972.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $972.8 million, a 5.32% decrease, with the full-year FY2025 number at $983.5 million, down 5.61% from a year prior.
  • Non-Current Assets hit $972.8 million in Q1 2026 for Neogenomics, down from $983.5 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $1.2 billion in Q1 2022 to a low of $972.8 million in Q1 2026.
  • Median Non-Current Assets over the past 5 years was $1.1 billion (2024), compared with a mean of $1.1 billion.
  • Biggest five-year swings in Non-Current Assets: skyrocketed 113.61% in 2022 and later dropped 5.61% in 2025.
  • Neogenomics' Non-Current Assets stood at $1.1 billion in 2022, then decreased by 4.44% to $1.1 billion in 2023, then decreased by 3.91% to $1.0 billion in 2024, then fell by 5.61% to $983.5 million in 2025, then fell by 1.09% to $972.8 million in 2026.
  • The last three reported values for Non-Current Assets were $972.8 million (Q1 2026), $983.5 million (Q4 2025), and $992.3 million (Q3 2025) per Business Quant data.